Compass Therapeutics (CMPX) Interest Coverage Ratio (2018 - 2021)
Compass Therapeutics recorded quarterly Interest Coverage Ratio of 333.36 in Q4 2021, down 344.17% quarter-over-quarter from 75.05 in Q3 2021.
Compass Therapeutics' Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 333.36 for Q4 2021.
- In Q4 2021, Interest Coverage Ratio changed N/A year-over-year to 333.36; the TTM figure through Sep 2022 stood at 1070.97 (down 765.47% YoY), while the FY2021 annual figure was 221.3, down 622.5% from the prior year.
- Interest Coverage Ratio came in at 333.36 for Q4 2021 at Compass Therapeutics, down from 75.05 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 7.09 in Q4 2019 to a low of 333.36 in Q4 2021.
- A 4-year average of 53.36 and a median of 24.0 in 2019 frame the typical range for Interest Coverage Ratio.
- On a YoY basis, Interest Coverage Ratio climbed as much as 33.06% in 2019 and fell as far as 166.1% in 2019.
- Compass Therapeutics' Interest Coverage Ratio stood at 10.59 in 2018, then soared by 33.06% to 7.09 in 2019, then slumped by 496.17% to 42.27 in 2020, then plunged by 688.66% to 333.36 in 2021.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 333.36, 75.05, and 51.68 for Q4 2021, Q3 2021, and Q1 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -333.36 |
| Sep 30, 2021 | -75.05 |
| Mar 31, 2021 | -51.68 |
| Sep 30, 2020 | -42.27 |
| Jun 30, 2020 | -20.95 |
| Mar 31, 2020 | -21.13 |
| Dec 31, 2019 | -7.09 |
| Sep 30, 2019 | -26.87 |
| Jun 30, 2019 | -27.62 |
| Dec 31, 2018 | -10.59 |
| Sep 30, 2018 | -10.10 |
| Jun 30, 2018 | -13.61 |